Dresden Glaucoma and Treatment Study (DGTS)

NCT02959242 · tracked via the Priya Life Science Germany tracker

Sponsor

Technische Universität Dresden

Phase

Observational

Started

2006-01

Last updated

2026-09-16

Condition(s) studied

GlaucomaGlaucoma, Open-AngleGlaucoma, Angle-ClosureGlaucoma, Low Tension

Study summary

To assure the quality of follow-up and treatment, data of glaucoma patients are stored and evaluated after anonymisation.

Eligibility

Sex

ALL

Min age

—

Max age

—

Healthy volunteers

Inclusion Criteria: * manifest glaucoma, ocular Hypertension, glaucoma suspect Exclusion Criteria: * under 18 years of age, corneal diseases

Primary outcome measure(s)

Follow-up intervals — 20 years
To find the best follow-up intervals for glaucoma patients.

Trial sites (1)

Facility	City	Region	Status
University Eye Hospital, Medical Faculty, Technical University Dresden	Dresden	Saxony	Recruiting

More Technische Universität Dresden trials in Germany

Re-irradiation of Recurrent Head and Neck Cancer Active, not recruiting

Pancreatic Head Resection or Total Pancreatectomy With Islet Autotransplantation in Patients With Periampullary Cancer and High Risk Profile for the Development of Postoperative Pancreatic Fistula Recruiting

Comparison of Proton and Photon Radiotherapy of Brain Tumors (ProtoChoice-Hirn) Recruiting

Gilteritinib in Combination With Venetoclax and Azacitidine for AML Patients With FLT3 Mutations Ineligible for Intensive Treatment Recruiting

A Retrospective Analysis of Magnetic Resonance Imaging Data for Breast Cancer Screening in the Open Consortium for Decentralized Medical Artificial Intelligence Active, not recruiting

Other trials for the same condition

Transcorneal Electrical Stimulation for the Treatment of Visual Field Defects in Patients With Open-Angle Glaucoma Recruiting

Alcon Hydrus Stent Implantation - Long Term Follow up After 8 Years Recruiting

Long-Term Clinical Results of Ab-Interno Trabeculotomy in Glaucoma Management Recruiting

Electrical Stimulation for the Treatment of Glaucoma Active, not recruiting

Retinal Ganglion Cell Neuroprotection Under Prostaglandin Analogues Starting soon

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT02959242 on ClinicalTrials.gov ↗ ← All trials in Germany